BUENA, N.J., Nov. 13, 2013 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based generic topical pharmaceutical company will be presenting at the Oppenheimer 24 th Annual Healthcare Conference. The Conference will take place on December 10 - 11, 2013 at the Crowne Plaza Hotel in New York, New York.
Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of IGI Laboratories, Inc. will present on Tuesday December 10, 2013, at 4:30 PM ET. Investors attending the conferences who wish to meet with Mr. Grenfell-Gardner and Mrs. Collins for a one-on-one meeting should contact their Oppenheimer representative or the Company.
The replay of the presentation will be webcast and will be available for 90 days online on the Investors section of the Company's website at http://www.igilabs.com.About IGI Laboratories, Inc. IGI Laboratories is a generic topical pharmaceutical company. We develop and manufacture topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leader in the generic topical prescription drug market. SOURCE IGI Laboratories, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts